Evidence reviewed
Scientific Mechanism
How Naltrexone Works
A neuropharmacological guide to naltrexone's mechanism of action, its effects on alcohol and opioid dependence, and the clinical evidence supporting its use.
Opioid receptor antagonism: the core mechanism
Naltrexone belongs to a class of drugs called opioid receptor antagonists. Its primary target is the mu-opioid receptor (MOR) — the same receptor that mediates the euphoric effects of alcohol, heroin, prescription opioids, and the body's own endorphins.
Unlike opioid agonists (morphine, methadone) or partial agonists (buprenorphine), naltrexone does not activate the receptor. Instead, it occupies and blocks it with high affinity, preventing other substances from binding. This blockade lasts 24–72 hours for a single 50 mg oral dose and approximately 28–30 days for the 380 mg extended-release injection.
Because naltrexone does not activate the receptor, it produces no euphoria, no physical dependence, and no withdrawal syndrome upon discontinuation. This distinguishes it fundamentally from replacement therapies and makes it a uniquely safe option for long-term use.
How opioid-receptor blockade matters
A simplified mechanism; clinical outcomes vary.
In simple terms
Competitive receptor binding
Naltrexone has high affinity for opioid receptors and competitively blocks opioid agonists and endogenous opioids from activating them.
Alcohol reward signalling
Opioid-receptor blockade can reduce part of alcohol's reinforcing response. It does not prevent intoxication, impaired judgment, or alcohol poisoning.
Direct opioid blockade
Usual opioid effects may be reduced or blocked. The blockade can be overcome by sufficiently high doses, which makes attempts to override it dangerous.
Treatment outcomes
Reduced heavy drinking, relapse prevention, craving, and retention are different outcomes. Effect depends on indication, adherence, setting, and support.
Alcohol dependence: why it works
Alcohol stimulates endorphin release, which activates mu-opioid receptors and triggers dopamine release in the nucleus accumbens — the brain's primary reward centre. This cascade creates the pleasurable sensations that reinforce drinking behaviour. Naltrexone interrupts this cascade at the first step. By blocking mu-opioid receptors, it prevents endorphins from triggering the dopamine response. Alcohol still causes intoxication and sedation through other pathways (GABA, glutamate), but the rewarding 'buzz' that drives compulsive drinking is substantially reduced. Over time, reduced reinforcement may weaken learned alcohol-reward associations for some people. Response varies, and the evidence does not support a guaranteed extinction timeline. This learning hypothesis is central to the Sinclair Method.
Clinical evidence
Key findings from systematic reviews, meta-analyses, and major randomised controlled trials.
- Randomised controlled trials
- 50
- Patients in largest trial
- 1383
- Reduction in heavy drinking
- 25–50%
- Lower relapse rate
- 36%
Included in the Cochrane systematic review of naltrexone for alcohol dependence
The COMBINE Study (JAMA, 2006) — the most comprehensive alcohol pharmacotherapy trial
Consistent across multiple meta-analyses compared to placebo
For opioid dependence at 6-month follow-up vs. placebo (Cochrane, 2011)
Research and mechanism questions
Does naltrexone work for everyone?
No. Average trial results cannot predict an individual's response. Benefit varies with the condition, outcome measured, adherence, treatment setting, and behavioural support.
How does naltrexone compare with acamprosate or disulfiram?
Naltrexone can help reduce heavy drinking; acamprosate is often used to support abstinence and is cleared mainly by the kidneys; disulfiram creates an adverse reaction with alcohol. Guidelines commonly treat naltrexone and acamprosate as first-line options rather than naming one universal winner.
How long does one oral dose block opioids?
US prescribing information reports that a 50 mg dose blocks the effects of 25 mg intravenous heroin for about 24 hours; double and triple doses produced blockade for roughly 48 and 72 hours in challenge studies. Individual response and clinical safety cannot be inferred from those experiments.
Does naltrexone affect the liver?
Clinicians consider symptoms, liver history, and laboratory results. Serious injury at standard doses appears uncommon, but naltrexone should be stopped and assessed if signs of acute hepatitis occur.
What happens if I use opioids while on naltrexone?
Effects may be reduced or blocked, but taking larger amounts to overcome the blockade is dangerous. Tell medical staff before surgery or emergency pain treatment, and discuss overdose prevention—including naloxone—with a clinician.
Primary source
- US naltrexone tablet prescribing information (DailyMed)
Mechanism, blockade duration, and overdose warnings; checked 26 July 2026.
Learn about the Sinclair Method
The Sinclair Method applies naltrexone's mechanism in a targeted way: take naltrexone only before drinking, not daily. Over time, the brain unlearns the alcohol-reward connection.